We are thrilled to announce that Pine Pharmaceuticals has been honored as Buffalo Business First's 2023 Business of the Year in the BioPharma sector! This remarkable achievement is a testament to the unwavering dedication and tireless efforts of our entire team,...
Staying current
and connected
See what we are doing, where we are going, and how we are shaping our industry every day.
Pine Pharmaceuticals’ Response to USP <797> Updates
On November 1, 2023, the United States Pharmacopeia (USP) introduced significant updates to USP Chapter <797>, a set of guidelines that regulates the integrity of sterile compounding processes in order to prevent microbial contamination and ensure patient...
Pine Pharmaceuticals launches seven new drug products to provide hospitals with life-saving resources nationwide
Tonawanda, NY, October 31, 2023 – Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, recently announced the launch of seven new hospital products, strengthening its ability to reduce drug shortages...
MasterControl Award: Excellence in Analytics
We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl. Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...
Compounding Pharmacy Compliance Conference 2023
We're thrilled to announce that our Director of Pharmacy Services and Regulatory Affairs, Allison Gentile, Pharm.D., will be a featured speaker at this year's Compounding Pharmacy Compliance 2023 event on August 17-18th. Learn more and see the full agenda here.
Pine Pharmaceuticals wins Brick by Brick Award
We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...
Introducing StaClear® Luer Slip and Norm-Ject® Less Fill
Pine Pharmaceuticals is pleased to introduce StaClear® Luer Slip and NORM-JECT® Less Fill, our all-new syringe options for repackaged bevacizumab. Designed to provide exceptional quality, StaClear® Luer Slip and NORM-JECT® Less Fill syringes now offer a low dead space...
Business First recognizes Pine Pharmaceuticals during 2023 Manufacturing Awards
We are pleased to announce that Buffalo Business First has named Pine Pharmaceuticals a 2023 Manufacturer Award winner. This award recognizes Pine as one of the top family-run businesses in the manufacturing industry and honors owners Al Sr. and Alfonse J. Muto for...
Pine Pharmaceuticals assumes Athenex’s 503B business, preserving over 50 jobs, expanding its product offerings, and serving hospitals and health systems nationwide
Tonawanda, NY, May 3, 2023 /PRNewswire/– Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, today announced the successful integration of Athenex's 503B business, including the transfer of people, processes,...
2023 Conferences and Trade Shows
March 17 - 19, 2023 Dallas, TXMay 17 - 20, 2023 Louisville, KY Learn moreMay 22 - 24, 2023 Indianapolis, IN Learn moreJuly 28 - August 1, 2023 Seattle, WA Learn moreAugust 15 - 16, 2023 Las Vegas, NV Learn moreJune 10 - 12, 2022 Orlando, FL Learn more October 23 - 25,...